Click it and Unblock the Notifications
For Quick Alerts
For Daily Alerts
Just In
Don't Miss
-
PAK vs NZ: Who is Haseebullah Khan? Learn All You Need To Know About Azam Khan's Replacement -
Yeh Rishta Kya Kehlata Hai New Cast Fees: Per-Episode Salaries Of Samridhii, Rohit & Others Revealed -
No Onboarding Of New Customers Via Online, Mobile Banking From April 24 At Kotak Bank; RBI Issues Ban -
iQOO Z9 Turbo Launched in China: Snapdragon 8s Gen 3, 16GB RAM, and More -
MP Board Class 10th, 12th Results 2024, Know Alternative Ways to Check Your Result -
Aston Martin Vantage Launched In India At Rs 3.99 Crore -
Mumbai Opens BMC Headquarters For Exclusive Heritage Tour -
Summer Style: 6 Must-Try Colors To Stay Fashionably Cool Like B-Town Divas!
GlaxoSmithKline India in deal with Japanese Daiichi
New Delhi, May 14 (UNI) Pharma giant GlaxoSmithKline Pharmaceuticals Ltd today said it has signed a co-production agreement with Japanese drugmaker Daiichi Sankyo.
The company has signed a co-production agreement with Japanese drug maker Daiichi Sankyo for anti-hypertensive drug Olmesartan Medoxomil and its combination products, the company said in a statement.
However, the company refused to disclose any financial details.
UNI
AK
PDT
DS1235
Comments
Story first published: Wednesday, May 14, 2008, 13:03 [IST]
